GI
IART icon

GAMMA Investing’s Integra LifeSciences IART Stock Holding History

GAMMA Investing’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$156K Sell
8,670
-78
-0.9% -$1.09K 0.01% 1465
2026
Q1 		$82.4K Buy
8,748
+2,441
+39% +$26.8K ﹤0.01% 1816
2025
Q4 		$78.3K Buy
6,307
+3,742
+146% +$49.7K ﹤0.01% 1748
2025
Q3 		$36.8K Buy
2,565
+913
+55% +$12.5K ﹤0.01% 2186
2025
Q2 		$20.3K Buy
1,652
+590
+56% +$8.57K ﹤0.01% 2451
2025
Q1 		$23.4K Buy
1,062
+430
+68% +$10.1K ﹤0.01% 2292
2024
Q4 		$14.3K Buy
632
+469
+288% +$10.2K ﹤0.01% 2437
2024
Q3 		$2.96K Sell
163
-178
-52% -$4.13K ﹤0.01% 2934
2024
Q2 		$9.94K Buy
341
+263
+337% +$7.8K ﹤0.01% 2256
2024
Q1 		$2.77K Buy
78
+35
+81% +$1.4K ﹤0.01% 2639
2023
Q4 		$1.73K Buy
+43
New +$1.69K ﹤0.01% 2621

Other funds holding IART

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
MAA
Mraz Amerine & Associates Modesto, California $697M AUM 19.37% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
CMA
Cedar Mountain Advisors Lake Oswego, Oregon $581M AUM 18.16% 1-Year Est. Return

GAMMA Investing's IART Position: Q2 2026 in Review

GAMMA Investing reduced its Integra LifeSciences (IART) stake by 0.89% in Q2 2026, selling an estimated $1.09K and leaving 8,670 shares worth $156K. The position accounts for 0.01% of the portfolio, ranked #1465.

GAMMA Investing first reported a position in IART in Q4 2023 and has held it in 11 quarters since. 16 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • GAMMA Investing held 8,670 shares of Integra LifeSciences worth $156K as of Q2 2026.
  • GAMMA Investing sold 78 Integra LifeSciences shares in Q2 2026, an estimated $1.09K.
  • Integra LifeSciences made up 0.01% of GAMMA Investing's portfolio in Q2 2026, its #1465 holding.
  • GAMMA Investing first reported a position in Integra LifeSciences in Q4 2023 and has held it in 11 quarters since.
  • 16 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.